| Source: |
| Type: |
| CSC markers include nanog, sox2, and oct3/4 CSC markers: CD55, CD133, ALDH1, SOX2, OCT4, NANOG, BMI1, ABCG2, CD24, EpCAM |
| 1168- | IVM, | SRF, | Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways |
| - | in-vitro, | HCC, | NA |
| 4961- | PEITC, | Phenethyl isothiocyanate suppresses cancer stem cell properties in vitro and in a xenograft model |
| - | vitro+vivo, | CRC, | HCT116 |
| 4959- | PEITC, | Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment |
| - | in-vitro, | Ovarian, | NA |
| 4898- | Sal, | Salinomycin as a potent anticancer stem cell agent: State of the art and future directions |
| - | Review, | Var, | NA |
| 5000- | Sal, | Salinomycin kills cancer stem cells by sequestering iron in lysosomes |
| - | vitro+vivo, | BC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:796 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid